Wall Street Eyes Hair Loss Treatments as the Next Obesity Drug Market
Driven by investor enthusiasm following the commercial success of GLP-1 weight-loss drugs, Wall Street has turned its financial focus toward the hair loss treatment market. Companies developing novel therapeutic candidates … Read More